Related Experiment Video
Updated: Aug 15, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest
Yi Chen1, Ze-Hong Miao, Wei-Min Zhao
1Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Science, Chinese Academy of Sciences, Shanghai, PR China.
Abstract:
The phytochemical 11,11'-dideoxyverticillin, derived from the fungus Shiraia bambusicola, has been shown to possess potent anticancer activity in vitro and in vivo. Here, we investigated the effect of 11,11'-dideoxyverticillin on cell cycle progression, and explored the potential mechanisms for this effect. A concentration- and time-dependent cell cycle blockade at G2/M phase was observed in human colon cancer cells (HCT-116) following 11,11'-dideoxyverticillin treatment and was associated with marked increases in levels of p53, phospho-p53(ser20) and phospho-Chk2(Thr 68). When wild type p53 expression was specifically inhibited by RNA interference, HCT-116 cells treated with 11,11'-dideoxyverticillin failed to arrest in G2/M and did not show increased phospho-Chk2(Thr 68). On the other hand, 11,11'-dideoxyverticillin treatment also elicited p38 MAP kinase activity and expression of phospho-p38 MAPK. Treatment with a specific p38 MAPK inhibitor (SB203580) successfully inhibited p38 MAPK and delayed the onset of G2/M arrest induced by 0.5 microM 11,11'-dideoxyverticillin after approximately 6 h, but did not abolish the induction of G2/M arrest. Additionally, SB203580 did not alter the levels of p53, phospho-p53 (ser20), or phospho-Chk2 (Thr68) proteins in 11,11'-dideoxyverticillin-treated cells. Together, these findings indicate that p53-mediated phosphorylation of Chk2 maybe plays a vital role in 11,11'-dideoxyverticillin-induced G2/M arrest, and that p38 MAPK might accelerate this progression. Our work suggests a new possibility of interactions among p53, Chk2 and p38 MAPK signaling in G2/M arrest.
Insights
The anticancer compound 11,11'-dideoxyverticillin halts colon cancer cell division at the G2/M phase. This cell cycle arrest is primarily mediated by the p53-Chk2 pathway, with p38 MAPK potentially accelerating the process.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- The Shiraia bambusicola fungus produces 11,11 -dideoxyverticillin, a phytochemical with known anticancer properties.
- Understanding the precise mechanisms of action for novel anticancer compounds is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of 11,11 -dideoxyverticillin on cancer cell cycle progression.
- To elucidate the molecular pathways involved in 11,11 -dideoxyverticillin-induced cell cycle arrest.
Main Methods:
- Human colon cancer cells (HCT-116) were treated with varying concentrations and durations of 11,11 -dideoxyverticillin.
- Western blotting was used to assess protein levels (p53, phospho-p53, phospho-Chk2, phospho-p38 MAPK).
- RNA interference was employed to inhibit p53 expression, and specific kinase inhibitors (SB203580) were used to block p38 MAPK activity.
Main Results:
- 11,11 -dideoxyverticillin induced a dose- and time-dependent G2/M phase cell cycle arrest in HCT-116 cells.
- The arrest was associated with increased levels of p53, phospho-p53(ser20), and phospho-Chk2(Thr 68).
- Inhibition of p53 abolished the G2/M arrest and phospho-Chk2 induction. p38 MAPK activation was observed, and its inhibition by SB203580 delayed but did not prevent the G2/M arrest.
Conclusions:
- The p53-mediated phosphorylation of Chk2 plays a critical role in 11,11 -dideoxyverticillin-induced G2/M cell cycle arrest.
- p38 MAPK signaling may act to accelerate this G2/M arrest.
- These findings suggest a complex interplay between p53, Chk2, and p38 MAPK in the cellular response to 11,11 -dideoxyverticillin.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

